{"id":4627,"date":"2025-05-28T14:20:30","date_gmt":"2025-05-28T12:20:30","guid":{"rendered":"https:\/\/www.symatese.com\/?p=4627"},"modified":"2025-05-28T14:04:46","modified_gmt":"2025-05-28T12:04:46","slug":"symatese-launches-its-estyme-injectable-range-in-france","status":"publish","type":"post","link":"https:\/\/www.symatese.com\/fr\/news\/symatese-launches-its-estyme-injectable-range-in-france\/","title":{"rendered":"SYMATESE lance sa gamme d'injectables ESTYME\u00ae en France"},"content":{"rendered":"<p>A l'occasion du congr\u00e8s SOFCEP-FILLTOX \u00e0 Monaco, SYMATESE est fi\u00e8re de pr\u00e9senter au march\u00e9 fran\u00e7ais sa gamme innovante d'injectables \u00e0 base d'AH*. D\u00e9velopp\u00e9s avec notre COLD-X TECHNOLOGY\u00ae, ces gels injectables offrent des r\u00e9sultats durables et naturels avec un excellent profil de s\u00e9curit\u00e9 confirm\u00e9 par de solides \u00e9tudes cliniques en Europe, aux Etats-Unis et en Chine.<\/p>\n<p>Cette \u00e9tape ne marque pas seulement notre entr\u00e9e sur le march\u00e9 fran\u00e7ais de l'esth\u00e9tique, mais renforce \u00e9galement notre strat\u00e9gie mondiale, apr\u00e8s un lancement r\u00e9ussi aux \u00c9tats-Unis et une expansion prochaine en Europe, en Chine et au Br\u00e9sil.<\/p>\n<p>Avec plus de 25 ans d'expertise en r\u00e9g\u00e9n\u00e9ration tissulaire et en m\u00e9decine esth\u00e9tique, SYMATESE continue de fa\u00e7onner l'avenir de l'innovation m\u00e9dicale.<\/p>\n<p><a href=\"https:\/\/www.symatese.com\/wp-content\/uploads\/2025\/05\/CP-Lancement-ESTYME\u00ae.pdf\" target=\"_blank\" rel=\"noopener\">Lire le communiqu\u00e9 de presse<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>*Acide Hyaluronique<\/p>","protected":false},"excerpt":{"rendered":"<p>During the SOFCEP-FILLTOX congress in Monaco, SYMATESE is proud to introduce its innovative range of HA*-based injectables to the French market. Developed with our COLD-X TECHNOLOGY\u00ae, these injectable gels provide long-lasting, natural-looking results with an excellent safety profile confirmed by robust clinical studies across Europe, the US, and China. This milestone not only marks our [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":4514,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"wds_primary_category":0,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-4627","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.symatese.com\/fr\/wp-json\/wp\/v2\/posts\/4627","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.symatese.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.symatese.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.symatese.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.symatese.com\/fr\/wp-json\/wp\/v2\/comments?post=4627"}],"version-history":[{"count":3,"href":"https:\/\/www.symatese.com\/fr\/wp-json\/wp\/v2\/posts\/4627\/revisions"}],"predecessor-version":[{"id":4629,"href":"https:\/\/www.symatese.com\/fr\/wp-json\/wp\/v2\/posts\/4627\/revisions\/4629"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.symatese.com\/fr\/wp-json\/wp\/v2\/media\/4514"}],"wp:attachment":[{"href":"https:\/\/www.symatese.com\/fr\/wp-json\/wp\/v2\/media?parent=4627"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.symatese.com\/fr\/wp-json\/wp\/v2\/categories?post=4627"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.symatese.com\/fr\/wp-json\/wp\/v2\/tags?post=4627"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}